STOCK TITAN

Planned 11,000-share sale at company (NASDAQ: ANAB) disclosed

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A security holder has filed to sell 11,000 shares of common stock. The shares are expected to be sold through Morgan Stanley Smith Barney LLC on the NASDAQ exchange around 01/15/2026, with an aggregate market value of $530,531.10 based on the filing.

The 11,000 shares to be sold were acquired on 01/15/2026 through a stock option exercise paid in cash. Shares of the issuer outstanding were 27,688,470, which provides a baseline for the size of this planned sale.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does this Form 144 filing for ANAB report?

The filing reports a planned sale of 11,000 shares of common stock by a security holder, to be executed through Morgan Stanley Smith Barney LLC on the NASDAQ exchange.

How many ANAB shares are planned to be sold and on what date?

The security holder plans to sell 11,000 common shares with an approximate sale date of 01/15/2026, as stated in the notice.

What is the aggregate market value of the ANAB shares to be sold?

The 11,000 common shares to be sold have an aggregate market value of $530,531.10 according to the information provided in the filing.

How were the ANAB shares being sold under Form 144 acquired?

The 11,000 shares were acquired on 01/15/2026 through a stock option exercise from the issuer, with the purchase price paid in cash.

How many ANAB shares were outstanding at the time referenced?

The filing lists 27,688,470 shares of the issuer’s common stock as outstanding, providing context for the size of the planned 11,000-share sale.

Which broker is handling the sale of these ANAB shares?

The planned sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, based at 1 New York Plaza, 8th Floor, New York, NY 10004.

Anaptysbio Inc

NASDAQ:ANAB

ANAB Rankings

ANAB Latest News

ANAB Latest SEC Filings

ANAB Stock Data

1.32B
26.01M
5.82%
124.31%
34.67%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO